ElsaLys Biotech
Lyon, Rhone-Alpes, France
About ElsaLys Biotech
ElsaLys Biotech, a Lyon & Illkirch Graffenstaden-France-based developer of therapeutic monoclonal antibodies, raised €2.1m in its first round of financing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.7M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2013)
- Website: elsalysbiotech.com
- Phone: +33 388404188
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/elsalys-biotech-2490251 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.